Cite
HARVARD Citation
Wagner-Johnston, N. et al. (n.d.). A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma. Leukemia & lymphoma. 56 (10), pp. 2863-2869. [Online].